Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × Antilymphocyte Serum × 1 year × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Leukemia, Myeloid, Acute 6 Myelodysplastic Syndromes 5 Lymphoma, Non-Hodgkin 4 Hematologic Neoplasms 4 Myeloproliferative Disorders 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Hodgkin Disease 3 Bone Marrow Failure Disorders 3 Multiple Myeloma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Biphenotypic, Acute 2 Vasculitis, Central Nervous System 1 Stiff-Person Syndrome 1 Shwachman-Diamond Syndrome 1 Sarcoma, Myeloid 1 Rhabdomyosarcoma 1 Recurrence 1 Rasmussen subacute encephalitis 1 Primary Myelofibrosis 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Opsoclonus-Myoclonus Syndrome 1 Non-Malignant Neoplasm 1 Neuromyelitis Optica 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1

Interventions

Carboplatin 4 pembrolizumab 3 Paclitaxel 3 Capecitabine 3 Azacitidine 3 venetoclax 2 pertuzumab 2 olaparib 2 durvalumab 2 Trastuzumab 2 Standard of Care 2 Oxaliplatin 2 Observation 2 Irinotecan 2 Immunotherapy 2 Immune Checkpoint Inhibitors 2 Chemoradiotherapy 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 taxane 1 talazoparib 1 tagraxofusp 1 sarilumab 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡